2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Completed
100
Unknown
57
Recruiting
54
Terminated
17
Not yet recruiting
11
Active not recruiting
11
Withdrawn
7
Suspended
2
Enrolling by invitation
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
1
Gastrointestinal
1
Conditions
Neoplasms
46
Breast Neoplasms
46
Colorectal Neoplasms
27
Prostatic Neoplasms
26
Carcinoma, Non-Small-Cell Lung
21
Leukemia, Myeloid, Acute
20
Glioblastoma
19
Melanoma
17
Lung Neoplasms
17
Pancreatic Neoplasms
16
Neoplasm Metastasis
16
Glioma
14
Stomach Neoplasms
13
Ovarian Neoplasms
13
Brain Neoplasms
13
Carcinoma, Hepatocellular
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Myelodysplastic Syndromes
11
Triple Negative Breast Neoplasms
10
Multiple Myeloma
10
Head and Neck Neoplasms
10
Carcinoma, Renal Cell
10
Lymphoma
9
Uterine Cervical Neoplasms
7
Sarcoma
7
Rectal Neoplasms
7
Leukemia
7
Hematologic Neoplasms
7
Esophageal Neoplasms
7
Colonic Neoplasms
7
Interventions
Radiotherapy
1
Oxaliplatin
1
Menogaril
1
Capecitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Suspended
×
Radiation Injuries
×
Clear all
NCT05820633
2025-09-12
PCS-XI
CHU de Quebec-Universite Laval
Phase NA
Suspended
500 enrolled
NCT02121405
2022-05-11
PSSR
Zhejiang University
Phase 3
Suspended
350 enrolled